Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Price:
108.58 USD
-1.73%
Market Closed
Updated:
May 17, 2024
Jazz Pharmaceuticals PLC
EPS (Diluted)
|
Jazz Pharmaceuticals PLC
EPS (Diluted) Peer Comparison
Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
EPS (Diluted)
$5
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
14%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
EPS (Diluted)
$0
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-167%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
EPS (Diluted)
$0
|
CAGR 3-Years
-308%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
EPS (Diluted)
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-34%
|
|
|
Ovoca Bio PLC
LSE:OVB
|
EPS (Diluted)
€0
|
CAGR 3-Years
0%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
9%
|
See Also
What is Jazz Pharmaceuticals PLC's EPS (Diluted)?
EPS (Diluted)
5.3
USD
5.3
USD
Based on the financial report for Mar 31, 2024, Jazz Pharmaceuticals PLC's EPS (Diluted) amounts to 5.3 USD.
What is Jazz Pharmaceuticals PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
14%
14%
The average annual EPS (Diluted) growth rates for Jazz Pharmaceuticals PLC have been -16% over the past three years , -9% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
